Abeona Therapeutics: 2Q Earnings Snapshot
DALLAS (AP) _ Abeona Therapeutics Inc. (ABEO) on Thursday reported a loss of $11.7 million in its second quarter.
The Dallas-based company said it had a loss of 25 cents per share.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The drug developer posted revenue of $819,000 in the period, which also missed Street forecasts. Five analysts surveyed by Zacks expected $1.8 million.
Abeona Therapeutics shares have decreased 8 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $14.55, an increase of 89 percent in the last 12 months.